TB-840

N/A

Report date: 2022/07/05 09:31:09

Base Information

Drug NameTB-840
Drug Alias NameTB-840
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor alpha
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTherasid Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherasid Bioscience Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A